VRCA

Verrica Pharmaceuticals (VRCA)

About Verrica Pharmaceuticals (VRCA)

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Details

Daily high

$8.92

Daily low

$7.23

Price at open

52 Week High

$9.82

52 Week Low

$3.28

Market cap

81.6M

Dividend yield

0.00%

Volume

Avg. volume

443,446

P/E ratio

-2.50

Verrica Pharmaceuticals News